Business
Found 606 articles
Eli Lilly Pushes Retatrutide Approval to 2027 After Strong Trial Results
Eli Lilly plans to file for regulatory approval of its experimental obesity drug, retatrutide, in early 2027, pushing back its original timeline. Despite the delay, the company confirmed that the drug successfully cleared two additional late-stage trials, demonstrating significant weight loss in patients with complex health complications.
Conservation Easements Face IRS Scrutiny Amid Legislative Expansion
While federal regulators continue to dismantle abusive tax shelters, Congress is moving to expand conservation easement incentives within the latest farm bill proposals. The initiative aims to support landowners who commit to permanent forest preservation, creating a divide between legitimate land stewardship and the syndicated schemes currently under intense audit.
American Airlines Trims Earnings Forecast Amid Rising Fuel Costs
Turbulence hit American Airlines on Thursday as the carrier slashed its 2026 earnings outlook, citing persistent volatility in fuel prices. The downward revision triggered an immediate slide in premarket trading, overshadowing a second-quarter performance that had managed to narrowly outpace Wall Street’s expectations for both revenue and adjusted earnings.
Comcast earnings reveal a tale of two companies
Ford and Geely forge electric vehicle alliance in Spain
Senate committee advances bill threatening Mercedes-Benz U.S. sales
EU Approves Paramount-Skydance Merger Following Distribution Concessions
Mediterranean Yacht Charters See Price Drops Amid Geopolitical Jitters
Nike Moves to Consolidate Chinese Digital Sales Channels
Kennedy Declares Cyclospora Outbreak Contained Amid Agency Scrutiny
Goldman Sachs pivots to direct private equity for wealthy clients
General Motors pivots back to combustion engines for Cadillac
Institutional Investors Offload Single-Family Homes Under New Bans
Novo Nordisk Sues Eli Lilly Over Allegedly Misleading GLP-1 Ad Campaigns
Jamie Dimon Warns Markets Are Blind to Looming Economic Shocks
General Motors Faces Profitability Test in Tuesday Earnings Report
Jamie Dimon Warns Markets Are Blind to Looming Economic Shocks
FDA maintains iceberg lettuce link despite false positive test result
Judge Halts Paramount and Warner Bros. Merger Over Antitrust Concerns
JetBlue Secures LaGuardia Slots Following Spirit Collapse
Military Testosterone Testing Raises Health Policy Questions
Robert Isom faces a $3 billion uphill climb at American Airlines
FAA Restores Boeing Authority to Certify 737 Max and 787 Jets
Cyclosporiasis Outbreak Triggers Market Jitters for Restaurant Chains
Chinese car sales surge as UK drivers trade tradition for value
The $69 Trillion Discrepancy in the Great Wealth Transfer
Inside the Chinese Crime Rings Targeting U.S. Retailers
Stagnation and High Costs Grip the Housing Market
Netflix Earnings Test Market Appetite for Ad-Tier Growth
